Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Terminated × Octreotide × Clear all

Phase

Phase 2 6 Phase NA 1 Phase 4 1 Phase 3 1

Status

Completed 3 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphocele 1 Breast Neoplasms 1

Interventions

Radiosurgery 22 Magnetic Resonance Spectroscopy 19 Surveys and Questionnaires 18 Radiotherapy 17 Blood Specimen Collection 17 Exercise 15 Radiotherapy, Intensity-Modulated 14 Cyclophosphamide 12 Acupuncture Therapy 12 Methods 11 Cisplatin 11 Biopsy 11 Standard of Care 10 Interviews as Topic 10 Filgrastim 10 Early Intervention, Educational 10 Surgical Procedures, Operative 9 Radiofrequency Ablation 9 Magnetic Resonance Imaging 8 fludarabine phosphate 7 Sorafenib 7 Radiation 7 Granulocyte Colony-Stimulating Factor 7 Colonoscopy 7 Brachytherapy 7 X-Rays 6 Therapeutics 6 Gemcitabine 6 Fluorodeoxyglucose F18 6 Educational Status 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03791736 2022-07-28

SANDOSTATINE

Institut Cancerologie de l'Ouest

Phase NA Terminated

Breast Neoplasms, Lymphocele

Data powered by HemOnc (CC BY 4.0) Colophon ⚡